NCT01854749已完成2 期
S1 Combined With Cisplatin in Treatment of Recurrence/Metastasis of ESCC Open-label Single Center Phase II Clinical Study
适应症
干预措施
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 57
- 试验地点
- 1
- 主要终点
- Progression Free Survival
研究概览
简要总结
Assess the efficacy and safety of S1 combined with cisplatin in treatment of recurrence/metastasis of ESCC
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 75 Years(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- •there is radical cure of the cancer
- •uncontrolled chronic diarrhea and esophageal obstruction
- •Neurological or mental abnormalities Influence of cognitive ability include central nervous system metastases
- •Severe complication(s), e.g.,uncontrolled active infection,myocardial infarction,hypertension,arrhythmia,stenocardia
- •Patient who has metastasis except cured skin basal cell carcinoma and carcinoma in situ of cervix
- •accept other antitumor therapy •Female patients during their pregnant and lactation period, or patients without contraception
研究组 & 干预措施
S1 combined with cisplatin
Experimental
干预措施: S1 combined with cisplatin (Drug)
结局指标
主要结局
Progression Free Survival
时间窗: from the first cycle of treatment (day one) to two month after the last cycle
次要结局
未报告次要终点
研究者
Chang Jian Hua
Deputy director of medical oncology
Fudan University
研究点 (1)
Loading locations...
相似试验
已完成
2 期
Phase 2 Study of S-1 in Combination With Cisplatin as 1st Line Therapy in Advanced Non-Small Cell Lung CancerAdvanced Non-Small Cell Lung CancerNCT00651833Taiho Oncology, Inc.60
已完成
1 期
Phase I/II study of cisplatin and S-1 with concurrent thoracic radiation therapy for inoperable locally advanced non-small-cell lung cancer (OLCSG 0501)inoperable locally advanced non-small-cell lung cancerJPRN-C000000079Okayama Lung Cancer Study Group60
Unknown
3 期
SP Intravenous Chemotherapy Versus SP by HIPEC in Stage Ⅲ Patients After D2 GastrectomyStage Ⅲ Gastric CancerNCT02396498Tang-Du Hospital270
已完成
1 期
Phase I/ II study of S-1 and cisplatin with concurrent radiotherapy for locally advanced non-small-cell lung cancer.ung cancerJPRN-UMIN000005389ational Cancer Center Hospital East45
已完成
2 期
A phase II study of S-1 plus cisplatin with concurrent radiation for locally advanced thymic carcinoma (LOGIK1605/JART-1501)Thymic carcinomaJPRN-UMIN000024643Clinical Research Support Center Kyushu30
